Hemato Oncology represents a rapidly advancing specialty focused on the diagnosis and management of blood cancers through precision medicine, molecular insights, and evolving therapeutic strategies. This focused session is designed to strengthen clinical understanding of hematological malignancies while integrating evidence-based treatment approaches and multidisciplinary care frameworks.
Upon completion of this session, participants will be able to:
Understand Disease Biology: Develop a strong foundation in the pathophysiology, classification, and evolution of hematological malignancies including leukemias, lymphomas, and plasma cell disorders
Strengthen Diagnostic Approach: Learn structured diagnostic pathways using hematological investigations, bone marrow evaluation, immunophenotyping, cytogenetics, and molecular diagnostics
Apply Risk Stratification Models: Interpret prognostic scoring systems and staging frameworks that guide treatment planning and outcomes
Review Treatment Strategies: Gain clarity on standard and emerging therapies including chemotherapy, targeted therapy, immunotherapy, and hematopoietic stem cell transplantation
Manage Treatment-Related Toxicities: Identify, prevent, and manage complications such as infections, cytopenias, bleeding risks, and organ toxicities
Integrate Multidisciplinary Care: Understand collaborative roles of oncology, hematology, pathology, transfusion medicine, and critical care teams
Enhance Clinical Decision-Making: Apply case-based learning to improve real-world patient management and treatment selection
Professor & Head – Department of Medical Oncology & Haemato-Oncology, St John’s Medical College & Hospital Senior Consultant – Haemato-Oncology, Cytecare Cancer Hospital
ASCO Direct™ is an officially licensed program of the American Society of Clinical Oncology®. ASCO® is a registered trademark of the American Society of Clinical Oncology. All rights reserved.